Cargando…
Circulating Tumor DNA: Less Invasive, More Representative Method to Unveil the Genomic Landscape of Newly Diagnosed Multiple Myeloma Than Bone Marrow Aspirates
SIMPLE SUMMARY: The study of malignant plasma cell DNA genomics in multiple myeloma is a hot topic, which is mainly based on one-site bone marrow aspirates. In this study, we showed that circulating tumor DNA targeted next-generation sequencing analysis revealed a more comprehensive genomic architec...
Autores principales: | Liu, Yang, Guo, Jiapei, Yi, Yuting, Gao, Xuan, Wen, Lei, Duan, Wenbing, Wen, Zhaohong, Liu, Yaoyao, Guan, Yanfang, Xia, Xuefeng, Ma, Ling, Fu, Rong, Liu, Lihong, Huang, Xiaojun, Ge, Qing, Lu, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563595/ https://www.ncbi.nlm.nih.gov/pubmed/36230837 http://dx.doi.org/10.3390/cancers14194914 |
Ejemplares similares
-
Is t(11;14)(q13;q32) good or bad for newly diagnosed multiple myeloma?
por: Liu, Yang, et al.
Publicado: (2023) -
Circulating tumour DNA sequence analysis as an alternative to multiple myeloma bone marrow aspirates
por: Kis, Olena, et al.
Publicado: (2017) -
Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma
por: Štifter, Sanja, et al.
Publicado: (2010) -
Cryopreservation Preserves Cell-Type Composition and Gene Expression Profiles in Bone Marrow Aspirates From Multiple Myeloma Patients
por: Chen, Duojiao, et al.
Publicado: (2021) -
PB2077: COMPARISON OF PLASMA CELL PERCENTAGE BY BONE MARROW ASPIRATE MORPHOLOGY AND CD138-STAINED BONE MARROW BIOPSY IN SMOLDERING MYELOMA TO PREDICT TRANSFORMATION TO SYMPTOMATIC MYELOMA
por: Cashman, Helen, et al.
Publicado: (2023)